Home > Insider Trading > Filing (0000899243-21-031417)

Filing Details

Accession Number:: 0000899243-21-031417
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-08-03 21:06:54
Reporting Period:: 2021-07-30

Accepted Time:: 2021-08-03 21:06:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1863294	Da32 Life Science Tech Acquisition Corp.	DALS	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1219042	Robert Nelsen	Da32 Life Science Tech Acquisition Corp 345 Park Avenue South, 12Th Floor New York NY 10010	No	No	Yes	No
1229592	Steven Gillis	Da32 Life Science Tech Acquisition Corp 345 Park Avenue South, 12Th Floor New York NY 10010	No	No	Yes	No
1569248	Kristina Burow	Da32 Life Science Tech Acquisition Corp 345 Park Avenue South, 12Th Floor New York NY 10010	No	No	Yes	No
1831802	Arch Venture Fund Xi, L.p.	Da32 Life Science Tech Acquisition Corp 345 Park Avenue South, 12Th Floor New York NY 10010	No	No	Yes	No
1847567	Arch Venture Partners Xi, L.p.	Da32 Life Science Tech Acquisition Corp 345 Park Avenue South, 12Th Floor New York NY 10010	No	No	Yes	No
1847601	Arch Venture Partners Xi, Llc	Da32 Life Science Tech Acquisition Corp 345 Park Avenue South, 12Th Floor New York NY 10010	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2021-07-30	1,600,000	$10.00	1,600,000	No	4	P	Direct
Class A Common Stock	Acquisiton	2021-07-30	650,000	$10.00	2,250,000	No	4	J	Indirect	Through A32 ponsor LC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	J	Indirect	Through A32 ponsor LC

Footnotes

ARCH Venture Fund XI, L.P. purchased 1,600,000 shares of the Issuer's Class A common stock for $10.00 per share in the Issuer's initial public offering.
This Form 4 is filed jointly by ARCH Venture Fund XI, L.P. ("AVF"), ARCH Venture Partners XI, L.P. ("AVP LP"), ARCH Venture Partners XI, LLC ("AVP LLC"), Kristina Burow, Robert Nelsen and Steven Gillis (collectively, the "Reporting Persons"). Keith Crandell has direct ownership of the Issuer's Class B Common Stock, as well as indirect pecuniary ownership of the Issuer's Class A common stock and Class B Common Stock and is filing his own Form 4 separately. Burow, Crandell, Nelsen and Gillis comprise the investment committee of AVP LLC (the AVP X Committee Members). Each of the Reporting Persons is a member of a Section 13(d) group. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of such Reporting Person's pecuniary interest therein.
DA32 Sponsor LLC ("Sponsor") purchased 650,000 shares of Class A common stock directly from the Issuer in a private placement for $10.00 per share, concurrently with the Issuer's initial public offering.
As a managing member of Sponsor, AVF may be deemed to beneficially own the securities owned directly by Sponsor. As the sole general partner of AVF, AVP LP may be deemed to beneficially own the securities owned directly by Sponsor. As the sole general partner of AVP LP, AVP LLC may be deemed to beneficially own securities owned directly by Sponsor. As the members of the investment committee, each of the AVP X Committee Members may be deemed to beneficially own securities owned directly by Sponsor. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of such Reporting Person's pecuniary interest therein.